5086 results about "Bioreactor" patented technology

The present invention provides a method of extracting and recovering embryonic-like stem cells, including, but not limited to pluripotent or multipotent stem cells, from an exsanguinated human placenta. A placenta is treated to remove residual umbilical cord blood by perfusing an exsanguinated placenta, preferably with an anticoagulant solution, to flush out residual cells. The residual cells and perfusion liquid from the exsanguinated placenta are collected, and the embryonic-like stem cells are separated from the residual cells and perfusion liquid. The invention also provides a method of utilizing the isolated and perfused placenta as a bioreactor in which to propagate endogenous cells, including, but not limited to, embryonic-like stem cells. The invention also provides methods for propagation of exogenous cells in a placental bioreactor and collecting the propagated exogenous cells and bioactive molecules therefrom.

A stable continuous method for producing ethanol from the anaerobic bacterial fermentation of a gaseous substrate containing at least one reducing gas involves culturing a fermentation bioreactor anaerobic, acetogenic bacteria in a liquid nutrient medium; supplying the gaseous substrate to the bioreactor; and manipulating the bacteria in the bioreactor by reducing the redox potential, or increasing the NAD(P)H TO NAD(P) ratio, in the fermentation broth after the bacteria achieves a steady state and stable cell concentration in the bioreactor. The free acetic acid concentration in the bioreactor is maintained at less than 5 g / L free acid. This method allows ethanol to be produced in the fermentation broth in the bioreactor at a productivity greater than 10 g / L per day. Both ethanol and acetate are produced in a ratio of ethanol to acetate ranging from 1:1 to 20:1.

A method of collecting embryonic-like stem cells from a placenta which has been treated to remove residual cord blood by perfusing the drained placenta with an anticoagulant solution to flush out residual cells, collecting the residual cells and perfusion liquid from the drained placenta, and separating the embryonic-like cells from the residual cells and perfusion liquid. Exogenous cells can be propagated in the placental bioreactor and bioactive molecules collected therefrom.

The present invention provides a method of extracting and recovering embryonic-like stem cells, including, but not limited to pluripotent or multipotent stem cells, from an exsanguinated human placenta. A placenta is treated to remove residual umbilical cord blood by perfusing an exsanguinated placenta, preferably with an anticoagulant solution, to flush out residual cells. The residual cells and perfusion liquid from the exsanguinated placenta are collected, and the embryonic-like stem cells are separated from the residual cells and perfusion liquid. The invention also provides a method of utilizing the isolated and perfused placenta as a bioreactor in which to propagate endogenous cells, including, but not limited to, embryonic-like stem cells. The invention also provides methods for propagation of exogenous cells in a placental bioreactor and collecting the propagated exogenous cells and bioactive molecules therefrom.

A bioreactor with substance injection capability. In one embodiment, the bioreactor includes a first substrate having a first surface, an opposite second surface and edges. The bioreactor further includes a second substrate having a first surface and an opposite second surface, defining a cavity with a bottom surface, where the bottom surface is located therebetween the first surface and the second surface. The first surface of the first substrate is received by the second surface of the second substrate to cover the cavity so as to form a chamber for receiving cells and a liquid medium. A port is formed in the second substrate between the bottom surface and the first surface of the second substrate. As formed, the port is in fluid communication with the chamber to allow a stream of substance to be introduced into the chamber. The stream of substance is controlled so as to provide a gradient, or a concentration gradient of the substance, to the chamber. The stream of substance includes a substance affecting the growth of cells such as chemokine.

Illumination systems, devices, and methods for cultivating biomasses. A bioreactor system is operable for growing photosynthetic organisms. The bioreactor system includes a bioreactor and an illumination system. The illumination system includes one more optical waveguides configured to light at least some of a plurality of photosynthetic organisms retained in the bioreactor. In some embodiments, the one or more optical waveguides include a plurality of structures configured to direct light energy from a solar energy collector, and a plurality of artificial light sources, along the interior of the waveguide. In some embodiments, the one more optical waveguides include a plurality of light-diffusing structures configured to guide at least a portion of the light from the solar energy collector and a plurality of artificial light sources directed along the interior of the waveguide, to the exterior of the waveguide.

The present invention discloses an indicator protein, and a method for making such a fusion protien, having a first binding moiety having a binding domain specific for a class of analytes that undergoes a reproducible allosteric change in conformation when said analytes are reversibly bound; a second moiety and third moiety that are covalently linked to either side of the first binding moiety such that the second and third moieties undergo a change in relative position when an analyte of interest molecule binds to the binding moiety; and the second and third moieties undergo a change in optical properties when their relative positions change and that change can be monitored remotely by optical means. The present invention also discloses a system and method for detecting glucose that uses such a fusion protein in a variety of formats including a subcutaneously and in a bioreactor.

Integrated systems including a photobioreactor system designed to contain a liquid medium comprising at least one species of phototrophic organism therein, and a facility associated with extracting and / or processing oil extracted from mixtures of oil and solid material, such as an oil sands facility, are described. Processes for using a photobioreactor system as part of a gas-treatment process and system able to at least partially remove certain undesirable pollutants from a byproduct gas stream produced by an oil sands facility are also described. Examples of such pollutants that may be removed include compounds contained within combustion gases, e.g., CO2 and / or NOx. These pollutants processed with the photobioreactor system, and, in some embodiments, biomass produced with the photobioreactor system may be utilized to produce a fuel source (e.g., biodiesel) and cutting stock for further operation of or use in the oil sands facility. Such uses of certain embodiments can provide an efficient means for recycling carbon, thereby reducing CO2 emissions, fuel, and / or cutting stock requirements for a given quantum of energy produced. In addition, in some cases the photobioreactor can be integrated with a holding pond and waste heat from the oil extraction process can be used to maintain the photobioreactor temperature and / or provide energy for other processes. Accordingly, embodiments described herein can improve the overall environmental and economic profile of the oil sands facility.

A device, method and process for three-dimensional spatial localization and functional interconnection of the same or different types of cells. The two or three-dimensional device comprising multiple layers containing wells for cell deposition where both the wells and layers are interconnected through microfluidic channels. A process for fabricating the three-dimensional device and a method for depositing different types of cells within the device in a functional interdependent spatial orientation thereby mimicking physiological functions. The device is useful for diagnostic assays, determination of dysfunction of certain cells in the system, quantification of production of cellular proteins, metabolites, hormones or other cellular products, for organ or tissue replacement, for co-culturing different cells, for testing pharmaceutical agents and as a bioreactor for production of biologicals.

A method of expanding / maintaining undifferentiated hemopoietic stem cells or progenitor cells by obtaining undifferentiated hemopoietic stem cells or progenitor cells; and either seeding the undifferentiated hemopoietic stem cells or progenitor cells into a stationary phase plug-flow bioreactor in which a three-dimensional stromal cell culture has been pre-established on a substrate in the form of a sheet, the substrate including a non-woven fibrous matrix forming a physiologically acceptable three-dimensional network of fibers, thereby expanding / maintaining undifferentiated hemopoietic stem cells or progenitor cells, or culturing the undifferentiated hemopoietic stem cells or progenitor cells in conditioned medium obtained from such a reactor.

A bioreactor and bioreactor system are suitable for the growth of materials from algae. More specifically, the system preferred embodiments use concentrated sunlight in a solo- or co-generation system to produce algae and products therefrom as well as solar thermal energy.

Systems, devices, and methods for releasing one or more cell components from a photosynthetic organism. A bioreactor system is operable for growing photosynthetic organisms. Some of the methods include contacting the photosynthetic organism with an energy-activatable sensitizer, and activating the energy-activatable sensitizer, thereby releasing a cellular component from at least one of, for example, a membrane structure, tubule, vesicle, cisterna, organelle, cell compartment, plastid, or mitochondrion, associated with the photosynthetic organisms.

The present invention relates to an integrated closed loop system for aquaculture in at least one culturing tank and using continuous bioreactor technology for the biological treatment and removal of organic material, nitrogen and phosphorous, comprising: an integrated, partially or wholly closed loop system for waste water treatment, where the water contains nitrogen containing compounds and / or substances, comprising at least one production unit of such nitrogen containing compounds and / or substances and using continuous bioreactor technology for the biological treatment and removal of organic matter, nitrogen and phosphorous from the said water at continuous flow, comprising: a) at least one suspended carrier bioreactor for bacterial growth under anoxic conditions to cause anaerobic denitrification, with one or several compartments, preceding b) at least one suspended-carrier bioreactor for bacterial growth under oxic conditions to cause aerobic nitrification, c) the denitrification taking place after the production unit, and d) the nitrification taking place prior to the production unit in a by-pass mode as part of the continuous flow.

The invention is directed to a ready-to-use modular cleanroom and facility, in particular for the production of drugs and biological substances, which is equipped with pre-approved manufacturing equipment cores. The modular cleanroom is implemented in the interior space of a container, such as a standard shipping container, and includes at least one bioreactor station. The modular facility can be installed on-site from pre-approved cleanroom modules without further regulatory approval. The cleanroom and facility comply with FDA-approved good manufacturing practices (GMP) and good laboratory practices (GLP).

A microfluidic device and method is disclosed for fractionating and / or trapping selected molecules with a diffusion barrier or porous membrane. The device includes a source fluid flow channel and a target fluid flow channel. The target fluid flow channel and the source fluid flow channel meet at cross-channel area and are in fluid communication with each other. A porous membrane separates the source fluid flow channel from the target fluid flow channel in the cross-channel area. A field-force / gradient mechanism may be positioned proximate the porous membrane with or without detection / state monitoring devices.

Contaminated wastewaters comprising biochemical oxygen demand (BOD), nitrogen and phosphorus are treated by an activated sludge process. The process utilizes an activated sludge tank, a solid-liquid separator, and a bioreactor to significantly reduce, or eliminate, waste activated sludge (WAS) within a sludge stream. A sidestream reactor is employed downstream from the bioreactor to remove soluble phosphates left in the sludge stream by the low WAS process. Within the sidestream reactor, a source of multivalent metal ions is added to a slightly alkaline sludge stream to precipitate the phosphates. The solid phosphates have a specific gravity higher than that of the organic matter in the sludge stream and may be separated from the sludge stream based upon differential settling velocity.

The present invention relates to an in vivo method of promoting the growth of autologous tissue and its use to form corrective structures, including tissue that can be explanted to other locations in the animal. In particular, the invention relates to methods and systems for (a) the site-specific regeneration of tissue, and (b) the synthesis of neotissue for transplantation.

The invention relates to a bioreactor for a cell treatment of a medium. Said bioreactor comprises an element defining a chamber in which cells for treating the medium are located, a liquid permeable membrane separating the said chamber from a first channel in which flows the medium to be treated, and a gas permeable membrane separating the said chamber from a second channel in which flows a gas containing oxygen.

A scaled-up multi-coaxial fiber bioreactor, and variations of this bioreactor. The device is characterized by a hollow housing and an array of from about 20 to about 400 modules of hollow fibers, where each module includes at least three coaxial semipermeable hollow fibers. The innermost fiber provides a boundary for an innermost compartment which is connected to inlet and outlet ports. Arranged coaxially around the central hollow fiber are several other hollow fibers with their respective compartments, each compartment defined by a respective annular space between adjacent fibers and each including inlet and outlet ports. An outermost compartment for permitting integral aeration is the space between the outer side of the outermost fibers and the inner side of the housing, and has inlet and outlet ports. The hollow housing has inlet and outlet manifolds and flow distributors for each of the compartments. In a preferred embodiment the bioreactor is used as an extracorporeal liver. Liver cells, are introduced into one or more annular compartments and media and aeration are provided in others. Plasma from an ailing patient is introduced into another compartment for biotransformation of blood-borne toxins and biosynthesis of proteins, lipids, and other metabolic products.

The present invention is a bioreactor wound dressing which includes a first layer, being a transport layer, in direct contact with a wound. It includes at least one layer of a permeable polymeric media containing, in equilibrium with body fluids, at least 40% by weight of liquid, and is impermeable for infectious agents of any kind and being permeable to water soluble substances having molecular weight up to at least 1000 Daltons. There is a second layer, being a fluid reservoir layer that is adjacent to the transport layer and is capable of containing between 40% and 100% of its volume of an aqueous liquid, wherein the transport layer and reservoir layer are permeably interconnected for aqueous solutions and are in a substantial osmotic equilibrium. The invention also includes a method of wound treatment utilizing the bioreactor wound dressing.

The present invention relates to methods and compositions for treating, ameliorating or preventing a disease or disorder in a subject by introducing into cells of the subject a therapeutic gene switch construct that controls expression of one or more therapeutic products.

Disclosed is a method for making a bioreactor comprising a foreign target gene, special selectable markers and Dunaliella Salina as host. It is prepared by the genetic transformation techniques that include introducing a foreign target gene into the cells of Dunaliella Salina and screening the transformed cells of Dunaliella Salina. The bioreactor of the present invention can be used as a safe and cheap production system for proteins of pharmaceutical interest including vaccines, especially oral products, in a large scale, because the cells of Dunaliella Salina are easy of genetic manipulation in preparation of the bioreactor, nontoxic and edible for humans and animals, and harmless to the environment.

A method and apparatus for growing algae for sequestering carbon dioxide and then harvesting the algae includes a container for a suspension of algae in a liquid and a bioreactor having a translucent channel in fluid communication with the container to absorb CO2 and grow the algae. A monitor determines the growth of the algae in the channel. A separator separates the grown algae from the suspension and an extractor extracts biomaterials from the grown algae.

An apparatus using activated sludge for the removal of biological nutrients from a wastewater includes a bioreactor for containing a mixture of wastewater under treatment and activated sludge. The bioreactor is divided into a plurality of serially connected treatment zones and includes a wastewater inlet, a downstream aerobic zone and an upstream aerobic zone between the wastewater inlet and the downstream aerobic zone, the upstream and downstream aerobic zones being separated by an anoxic zone. A method for removal of nutrients from a wastewater includes providing a wastewater to an inlet of a serial, multi-zone, activated sludge bioreactor containing an activated sludge. The bioreactor has a downstream aerobic zone from which water is removed and an upstream aerobic zone between the wastewater inlet and the downstream aerobic zone, the upstream and downstream aerobic zones being separated by an anoxic zone.

Provided is an oriented multilayer porous film comprising at least one layer comprising: a heat, solvent, and degradation resistant matrix polymer; a plurality of interconnecting pores; and a porosity less than 90%. The film is made by a dry and / or wet method, with its multilayer structure constructed by coextrusion, lamination, and coating. The film of this disclosure finds a wide range of applications as a permselective medium for use in energy harvesting and storage, filtration, separation and purification of gases and fluids, CO2 and volatile capture, electronics, devices, structural supports, packaging, labeling, printing, clothing, drug delivery systems, bioreactor, and the like. The film is preferably used as a separator of lithium-ion, lithium-sulfur, lithium-air, metal-air, and nonaqueous electrolyte batteries.

The present invention relates to an integrated closed loop system for aquaculture in at least one culturing tank and using continuous bioreactor technology for the biological treatment and removal of organic material, nitrogen and phosphorous, comprising: an integrated, partially or wholly closed loop system for waste water treatment, where the water contains nitrogen containing compounds and / or substances, comprising at least one production unit of such nitrogen containing compounds and / or substances and using continuous bioreactor technology for the biological treatment and removal of organic matter, nitrogen and phosphorous from the said water at continuous flow, comprising: a) at least one suspended carrier bioreactor for bacterial growth under anoxic conditions to cause anaerobic denitrification, with one or several compartments, preceding b) at least one suspended-carrier bioreactor for bacterial growth under oxic conditions to cause aerobic nitrification, c) the denitrification taking place after the production unit, and d) the nitrification taking place prior to the production unit in a by-pass mode as part of the continuous flow.

An inter-zone aerobic to anoxic zone flow rate control system for single vessel multi-zone bioreactor plants for wastewater treatment is described herein. The system of the invention provides control of the relative treatment times of the mixed liquor in the horizontally disposed and adjacent aerobic and anoxic treatment zones of the bioreactor by providing one or more flow rate adjusting gates located between the aerobic and anoxic zones of the bioreactor. The opening of the gates is adjustable in accordance with sensed conditions in the treatment zones. An automated embodiment of the invention includes a programmable logic controller that provides control scripts for adjusting the opening of one or more flow control gates according to inputs from sensors and per programmed instructions. An automated and supervised embodiment of the invention includes a computer interfaced with a programmable automating controller. The computer provides status reports, commands to the programmable automating controller, storage and analysis of data, as well as a means of communicating to remote monitoring centers and networks.

Methods and compositions disclosed herein generally relates to methods of determining minimum hematopoietic stem cell (HSC) chimerism and gene dosage for correction of a hematopoietic disease; in particular, in in vivo models. The invention also relates to modified lentiviral expression vectors for increase a viral titer and various methods for increasing such titers as well as expression vectors capable of enhancing such titers. The invention also relates to CHS4 chromatin insulator-derived functional insulator sequences. The invention further relates to methods for genetic correction of diseases or reducing symptoms thereof, such as sickle cell anemia, a lysosomal storage disease. The invention further relates to a method of improving and / or correcting one or more central nervous system (CNS) abnormalities caused by one or more lysosomal storage disease. The invention further relates to methods of improving titer in transfection-based bioreactor culture production or transfection-based production systems using eukaryotic cells.

A method is provided to produce biodiesel from algae using a strain of microalga chlorella protothecoids, by screening a specific strain with characteristics of high yield of biomass and high oil content, cultivating the screened strain for high-cell-density growth for up to 108 grams of dry cell weight per liter of the suspension in a bioreactor using solutions containing carbohydrates as feed, harvesting and drying the high density cultivated algal cells to extract oil from the dried algal cells, and producing the biodiesel by reaction of catalyzed transesterification using the extracted oil as feedstock.

A method and apparatus for sequestering CO2 using algae comprises a plurality of vertically suspended bioreactors, each bioreactor being translucent and including a flow channel formed by a plurality of baffles. A culture tank contains a suspension of water and at least one algae and includes a plurality of gas jets for introducing a CO2-containing gas into the suspension. The culture tank is in fluid communication with an inlet in each channel for flowing the suspension through the channel in the presence of light. A pump pumps the suspension into the channel inlet.